Featured Stories
Medis Received the Platinum Creditworthiness Certificate of Excellence for 2020
The Bisnode Analytics Services has ranked Medis among the 1.5% of the most successful, reliable, credible and low-risk companies for cooperation with other...
Read More
A new partnership with Neurim Pharmaceuticals Ltd.
Our exclusive distribution agreement for the commercialization of Slenyto® represents an important milestone for both companies.
Read More
In 2019 Medis generated 70% revenues from international markets
The rapid expansion and the introduction of important novel therapeutic options further enhanced the position of Medis as the leading independent company for...
Read More
Martina Perharič, the CEO of Medis, Recipient of the 2019 Artemis Award
The Managers’ Association of Slovenia presented the award for outstanding achievements in the field of management to Martina Perharič, the CEO of Medis.
Read More
Medis is now present also in the Baltic countries and Slovakia
From 2020, Medis offers its partners a single entry point for 15 countries in the CEE region.
Read More
Catch the healthy rhythm in 2020!
The rhythm of the heart, the rhythm of youth, the rhythm of the senses, the rhythm of words, the rhythm of music and the rhythm of dance ... in the new year,...
Read More